vTv Therapeutics (VTVT) Reports In-Line Q3 EPS

vTv Therapeutics (NASDAQ: VTVT) reported Q3 EPS of ($0.08), in-line with the analyst estimate of ($0.08).

For earnings history and earnings-related data on vTv Therapeutics (VTVT) click here.

You May Also Be Interested In

• KB Home (KBH) Tops Q3 EPS by 16c
• AutoZone (AZO) Tops Q4 EPS by $1.76, Misses on Revenue
• MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance